Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PER2 | O15055 | 16/20 | 0.39 |
| ▸ | CRY1 | Q16526 | 16/20 | 0.39 |
| ▸ | CRY2 | Q49AN0 | 16/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTR4 | Q13639 | 4/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3035583 | 1.00 | PER2 (0.39) | PER2CRY1CRY2ALDH1A1HTR4 | |
| SCHEMBL4669731 | 1.00 | PER2 (0.39) | PER2CRY1CRY2ALDH1A1HTR4 | |
| SCHEMBL2918659 | 1.00 | PER2 (0.39) | PER2CRY1CRY2ALDH1A1HTR4 | |
| SCHEMBL2911931 | 1.00 | PER2 (0.39) | PER2CRY1CRY2ALDH1A1HTR4 | |
| SCHEMBL3040095 | 1.00 | PER2 (0.39) | PER2CRY1CRY2ALDH1A1HTR4 | |
| Hydrochloric Acid SCHEMBL2912478 | 0.99 | PER2 (0.38) | PER2CRY1CRY2ALDH1A1HTR4 | |
| SCHEMBL3043624 | 0.88 | PER2 (0.42) | PER2CRY1CRY2 | |
| SCHEMBL3792794 | 0.88 | PER2 (0.42) | PER2CRY1CRY2 | |
| SCHEMBL3045274 | 0.87 | — | — | |
| SCHEMBL1073407 | 0.86 | HTR4 (0.34) | HTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231589-B1 | AMINOTETRALIN COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | THERAVANCE INC (US) | 2013-02-13 | — | — | EP | disclosed |
| EP-1874766-B1 | CRYSTALLINE FORM OF A QUINOLINONE-CARBOXAMIDE COMPOUND | THERAVANCE INC (US) | 2010-09-01 | — | — | EP | disclosed |